SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 86,600
+4,400 (5.35%)
At close: Jun 24, 2026
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 6.44 trillion as of June 24, 2026. Its market cap has decreased by -9.47% in one year.
Market Cap
6.44T
Enterprise Value
6.18T
Revenue
790.25B
Ranking
n/a
PE Ratio
18.46
Stock Price
86,600.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 6.44T, a decrease of -35.28%. That is a compound annual growth rate of -7.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 6.44T | -34.03% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Epis Holdings | 10.67T |
| Kolon TissueGene | 8.67T |
| HLB Co., Ltd. | 6.39T |
| LigaChem Biosciences | 4.96T |
| D&D Pharmatech | 4.87T |
| Peptron | 4.77T |
| Voronoi | 3.51T |
| PharmaResearch | 3.05T |